Y-mAbs Therapeutics, Inc. earnings per share and revenue

YMAB earnings per share for the last quarter are -0.16 USD whereas the estimation was -0.16 USD which accounts for -1.39% surprise. Company revenue for the same period amounts to 18.46 M USD despite the estimated figure of 23.28 M USD. Estimated earnings per share for the next quarter are -0.11 USD, and revenue is expected to reach 26.95 M USD. Also watch annual changes over time to get a bigger picture of YMAB earnings per share and revenue dynamics.